- Home
- ZBIO vs WTF Comparison
ZBIO vs WTF Comparison
Compare ZBIO & WTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- WTF
- Stock Information
- Founded
- ZBIO 2019
- WTF 1989
- Country
- ZBIO United States
- WTF Hong Kong
- Employees
- ZBIO N/A
- WTF N/A
- Industry
- ZBIO
- WTF
- Sector
- ZBIO
- WTF
- Exchange
- ZBIO NYSE
- WTF NYSE
- Market Cap
- ZBIO 389.2M
- WTF 339.6M
- IPO Year
- ZBIO 2024
- WTF 2025
- Fundamental
- Price
- ZBIO $9.09
- WTF $7.19
- Analyst Decision
- ZBIO Strong Buy
- WTF
- Analyst Count
- ZBIO 7
- WTF 0
- Target Price
- ZBIO $32.29
- WTF N/A
- AVG Volume (30 Days)
- ZBIO 147.9K
- WTF 264.8K
- Earning Date
- ZBIO 05-27-2025
- WTF 01-01-0001
- Dividend Yield
- ZBIO N/A
- WTF N/A
- EPS Growth
- ZBIO N/A
- WTF N/A
- EPS
- ZBIO N/A
- WTF 0.04
- Revenue
- ZBIO $5,000,000.00
- WTF $10,508,879.00
- Revenue This Year
- ZBIO N/A
- WTF N/A
- Revenue Next Year
- ZBIO N/A
- WTF N/A
- P/E Ratio
- ZBIO N/A
- WTF $205.77
- Revenue Growth
- ZBIO N/A
- WTF 4482.47
- 52 Week Low
- ZBIO $5.83
- WTF $4.05
- 52 Week High
- ZBIO $26.25
- WTF $19.85
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- WTF N/A
- Support Level
- ZBIO N/A
- WTF N/A
- Resistance Level
- ZBIO N/A
- WTF N/A
- Average True Range (ATR)
- ZBIO 0.00
- WTF 0.00
- MACD
- ZBIO 0.00
- WTF 0.00
- Stochastic Oscillator
- ZBIO 0.00
- WTF 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About WTF WATON FINANCIAL LIMITED
Waton Financial Ltd is a holding company that operates its business through subsidiaries in the securities brokerage and distribution services, margin financing services, and other ancillary services business; Software licensing and related support services, including licensing of trading platform applications, upgrades and enhancements, maintenance; and other associated services to securities brokers and financial institutions. The group also provided software licensing and related support services, including licensing trading platform applications, and others.